Download pdf - Investor deck (fy17 q2) final v2

FY17 Q2 Investor Deck

Safe Harbor Except for historical information, matters discussed in this presentation, including statements about the success of the Company’s

future volume, sales, costs, cost savings, earnings, foreign currencies, and foreign currency exchange rates, cash flows, plans,

objectives, expectations, growth or profitability, are forward-looking statements based on management’s estimates, assumptions

and projections. Important factors that could affect performance and cause results to differ materially from management’s

expectations are described in the Company’s most recent Form 10-K filed with the SEC, as updated from time to time in the

Company's SEC filings. Those factors include, but are not limited to, risks related to competition in the Company’s markets;

economic conditions and financial market volatility; the Company’s ability to drive sales growth and increase market share; volatility

and increases in commodity, energy and other costs; dependence on key customers; information technology security breaches or

cyber attacks; government regulations; political, legal and tax risks; international operations, including price controls, foreign

currency fluctuations, labor claims and labor unrest, potential harm and liabilities from use, storage and transportation of chlorine in

certain markets and discontinuation of operations in Venezuela; risks relating to acquisitions, new ventures and divestitures; the

success of the Company’s business strategies and products; supply disruptions; product liability claims, labor claims and other

legal proceedings; the Company’s business reputation; environmental matters; the Company’s ability to assert and defend its

intellectual property rights; and the impacts of potential stockholder activism.

The Company may also use non-GAAP financial measures, which could differ from reported results using Generally Accepted

Accounting Principles (GAAP). The most directly comparable GAAP financial measures and reconciliation to non-GAAP financial

measures are set forth in the Appendix hereto, the Supplemental Schedules of the Company’s quarterly financial results and in the

Company’s SEC filings, including its Form 10-K and its exhibits furnished to the SEC, which are posted at

www.TheCloroxCompany.com in the Investors/Financial Information/Financial Results and SEC Filings sections, respectively.

International : 17% Cleaning : 33%

Household : 33% Lifestyle : 17%

Cleaning 33%

Household 33%

Lifestyle 17%

International 17%

Advantaged Portfolio

Over 80% of Sales From #1 or #2 Share Brands

Latin America 9%

Canada 3%

Australia / NZ 2%

Rest of World 3%

9%

4%

4%

15%

11%

6%

Home Care 18%

Laundry 9%

Professional 6%

FY16 Company Sales: $5.8B

<1%*

Note: Reflects results following May 2016 Acquisition. Expect Renew Life to contribute 2pts of Sales in FY17

http://www.cloroxcsr.com/category-detail.php?catName=commercialsolutions


Big Share Brands in Mid-Sized Categories

Clorox 23%

Private Label 20%

Competitor A 8%

Competitor B 5%

Competitor C 5%

Competitor D 4%

Competitor E 4%

Smaller Players

32% Clorox is

~3X

the size of next

branded competitor

Source: IRI MULOP for 52 weeks ending 12/18/2016

Private Label 17%

Other 9%

Glad* 31%

Private Label 44%

Hefty 17%

Other 8%

Advantaged Portfolio Strong Position in Categories with Private Label Exposure

Clorox 59%

Private Label 35%

Other 6%

Bleach Trash Bags Charcoal

Kingsford

74%

*Glad >50% Share of Premium Trash

Source: IRI MULOP for 52 weeks ending 12/18/2016


Supported by Consumer Megatrends

Affordability

Health & Wellness Sustainability

Fragmentation

MEGA

TRENDS


Driving Significant Synergies

Over 80% of sales from #1 or #2 share brands

Lower SG&A as a % of Sales vs. Peers(1)

Top tertile ROIC

Strong cash flow

Customer

Scaled teams,

capabilities, and

broker network

Supply Chain

Scale across Buy,

Make, Ship

Brand Building

Common consumer

trends, insights, 3D

demand creation

Health & Wellness Sustainability Fragmentation Affordability

(1) As of June 30th, 2016, Clorox’s S&A/Sales was ~14% vs. peer average of 20% . This number does not include R&D or marketing expenses and excludes peers that do

not disclose S&A separately from SG&A in their reported financial statements (Kimberly-Clark, Reckitt-Benckiser). Peer group consists of CHD, CL, PG, NWL, CPB, GIS,

HSY, K, KHC, DPS, KO, PEP, COTY, EL, KMB, RB-GB.


2020 Strategy

Mission

Strategy Strategy

Objectives

• We make everyday life better, every day

• Maximize economic profit across categories, channels, and countries

• Big-share brands in midsized categories and countries

• Engage our people as business owners

• Increase brand investment behind superior value and more targeted

3D plans

• Keep the core healthy and grow into new categories, channels, and

existing countries

• Reduce waste in work, products, and supply chain to fund growth

Long-Term Growth Algorithm Remains Unchanged

~80% of Clorox Sales

+2-4% annual growth

1.5 - 3.0 pts

company growth

U.S. Domestic


+5-7% annual growth

1.0 - 1.5 pts

company growth

International

Annual EBIT Margin Improvement: +25 to +50 bps

Annual Free Cash Flow: 10% to 12% of Sales

= +3 to +5pts company

growth

Strong Progress Across Strategy Accelerators

New, Digital-Led Creative Agency Partners

Cutting Speed to Market by 50%

Investing Behind Growth Brands to Accelerate Top-line

FY16 Record-High Engagement

Increased Investments in Profitable Growth

Focus on Core

Increased Demand

Investment

Investments in

Innovation

Sales Promotion

Trade Promotion

Advertising

+2pts

Leading Through Strategic Change in CPG

Digital

Revolution

Consumer

Focus on Value

Challenging

Retail Environment

International

Macro Headwinds

Focus on Portfolio Momentum

Portfolio Segmentation

Sales Growth Potential

High

Low High

Fuel Growth

1 point of Household Penetration = $50M+ Sales

$22M $20M $10M

Cleaning Household Lifestyle

Opportunity by Segment

New Usage Occasions → Household Penetration

New Faces New Demographic or

Behavioral Group

New Spaces Consumes Product in a

New Way

New Places New Channel or

Location in Store

Growth With New Faces, Spaces & Places

Drive

Trial & Awareness on Core

Expand into Adjacencies

International Expansion

Growth With New Faces, Spaces & Places

Targeted Demand

Spend

Drive New

Usage Occasions

Expand Retail Distribution

Margin Enhancement through Operational Excellence

Renew Life Acquisition

• Closed May 2, 2016

• Purchase Price – $290M (2.5x Sales)

• Calendar 2015 Sales – About $115M

• Leading brand in the natural channel

Source: SPINS with Vitamin Shoppe, IR MULO 52 weeks ending 7/10/16, and Whole Foods 52 weeks ending 7/10/16

Probiotics: An Attractive Category

Two-thirds of US consumers

experience digestive health issues

50% of purchases are based

on a Doctor recommendation

+15% expected category growth

Source: Mintel Group, Ltd. (2015), Estimates based on Mintel (2015), Nutrition Business Journal (2014), and Euromonitor (2015) total market estimates in

food, drug, mass, natural, eCommerce, specialty and other channels

Renew Life: Strong Strategic Fit

Health & Wellness

US Centric

Clear Plan for Value Creation

Focus on 3D Innovation

Broad-based Approach to Innovation

Product & Marketing

Product Superiority

Cost-o-vation*

New Product

Platforms &

Adjacency Expansion

GROW MARKET SHARE

ACCELERATE GROWTH EXPAND MARGIN

KEEP THE CORE HEALTHY

*Cost-o-vation is a term used at Clorox that describes innovation that improves product performance at a reduced cost.

Innovation is Delivering Growth

3.3% 3.4%

2.9% 3.0% 2.7%

0%

1%

2%

3%

4%

5%

FY12 FY13 FY14 FY15 FY16 Goal

3.0%

Incremental Sales Growth from Innovation (Last 12 months)

Source: Clorox Internal

Strong Product & Commercial Innovation

Burt’s Natural Lipsticks

Fresh Step with Febreze Hidden Valley with Greek Yogurt

Clorox Wipes with Micro-Scrubbers

Glad with Clorox Antimicrobial

Clorox Bleach Crystals Stephen Curry

Partnership Brita Infinity

“Connected” Pitcher

Clorox Clothes (International)

Generating Long-Term Value From Innovation

Increased Demand

Investment

Optimize the

3Ds

Internal

3-Year Metric

Sales Promotion

Trade Promotion

Advertising

+2pts

3-Year Metric to Improve Innovation “Stickiness”

Internal

3-Year Metric

• Increase year 2 & 3 spending on successful

innovation

• Leverage platforms to allow for “Blockbuster”

introductions, followed by “Sequels”

• More “Adjust & Nurture” post-launch for

slower building innovations

Blockbuster & Sequels

Differentiated Technology Provides Staying Power

Faster Time to Market

Goal: Reduce time to market by 50%

- Accelerate decision making

- Right-sized testing plans

- Faster, more efficient development

process

Improving Value via Consumer Value Measure (CVM)

Product

Experience

Perception

Price

To Date Process

60/40 Testing

FY16 & Beyond

Total Consumer

Value

60/40 Testing

Price

Brand Equity

Consumer Value Measure

Product Experience x Perception

Price

Superior Value

Parity Value

Inferior Value

• Proprietary real-time data

• Correlates to change in market share

• Captures all value drivers

Total Consumer

Value

CVM: How Do We Use It?

Price Index

Pro

duct

& P

erc

eption Index

Product x Perception

Price

Category Average

Based on Marn, Roegner, Zawada (McKinsey) pricing work published in “The Pricing Advantage” (April 2004)

Above 450 line,

Benefit > Price

Superior

Value

Below 450 line

Price > Benefit

Inferior

Value

Focus on 3D Technology Transformation

Technology Reshapes Consumer Journeys

Leading the Industry in Digital Consumer Engagement

More Targeted

More Personal

More Real-Time

Driving Consumer Engagement

Accelerating Investments in Digital Media

Clorox projecting

to invest 45%

of our media in

digital

45%

FY14 FY15 FY16 FY17 Proj.


Technology Enables One-to-One Communication

R E C I P E S

Right Message,

Right Context,

Right Medium

Digital Improves ROI

Enhanced

Targeting

More

Personalized

More

Real Time Across

Channels

We Leverage our Location for Innovative Partnerships

Strong Momentum in eCommerce

FY13 FY14 FY15 FY16

~2x Sales Growth (FY16 vs FY13)


eCommerce-Enabled Innovation

eCommerce-Enabled Innovation

Infinity Pitcher

Focus on Growth Culture

Strong Organizational Culture is a Solid Foundation

Strong Values

People Centric

Operational Excellence

Winning the Right Way

Corporate Responsibility at Clorox

<A> Reviewed by Ernst & Young LLP Footnotes: http://annualreport.thecloroxcompany.com/_pdf/CLX-012_2016_Integrated_Report.pdf page 27

http://annualreport.thecloroxcompany.com/_pdf/CLX-012_2016_Integrated_Report.pdf




Clorox Engagement Exceeds Global Benchmarks

<A> Reviewed by Ernst & Young LLP Footnotes: http://annualreport.thecloroxcompany.com/_pdf/CLX-012_2016_Integrated_Report.pdf page 26





International : 17% Cleaning : 33%

Household : 33% Lifestyle : 17%

Cleaning 33%

Household 33%

Lifestyle 17%

International 17%

Latin America 9%

Canada 3%

Australia / NZ 2%

Rest of World 3%

9%

4%

4%

15%

11%

6%

Home Care 18%

Laundry 9%

Professional 6%

FY16 Company Sales: $5.8B

<1%*

International is a Key Component of our Portfolio

Note: Reflects results following May 2016 Acquisition. Expect Renew Life to contribute 2pts of Sales in FY17


Why We Like International

Leading Brands

Midsized Countries

Faster

Category Growth Rates

Strong

Operational Performance

Peru

International: “Go Lean” Approach

Pricing

Maximization

Focus on

Cost Savings

Right-Size

Infrastructure

Optimize Demand Creation

Pricing

Maximization

Focus on

Cost Savings

Right-Size

Infrastructure

Optimize Demand Creation

4 Pillars of Profitability

We Have Strong Leading Brands Across International

45 Brands Hold

#1 or #2 Market Share

Source: Nielsen Retail Measurement for International geographies except; IRI for Australia, Horwath for Dominican Republic and

IDRetail for Uruguay ending FY16

FY17 Outlook Based on Feb 3rd Earnings Call

• Categories: about 1%

• Innovation: +3pts

• Renew Life: +2pts

• Mix/Other: about -1pt

• FX: -1pt to -2pts Sales

+3% to +4%

EBIT Margin +25 to +50bps

Diluted EPS $5.23 to $5.38

(+6% to +9%)

• Gross Margin: Down Slightly

• Selling & Admin: <14% of Sales

• Advertising & Sales Promotion: about 10% of Sales

• Tax rate: 32% to 33%

EBIT (a non-GAAP measure) represents earnings from continuing operations before income taxes (a GAAP measure), excluding interest income &

interest expense. EBIT margin is a measure of EBIT as a percentage of sales.

FY17 YTD Performance

Sales

EBIT Margin

Diluted EPS (cont. ops)

FY17 YTD Vs. Year Ago

$2.8B +4%

(+6% FX Neutral)

18.7% -90 bps

$2.50 +2%

EBIT (a non-GAAP measure) represents earnings from continuing operations before income taxes (a GAAP measure), excluding interest income & interest expense. EBIT margin is a

measure of EBIT as a percentage of sales. See reconcilation on our website (https://investors.thecloroxcompany.com/investors/financial-information/quarterly-results/default.aspx) and on

slide 70. Currency Neutral Sales growth (a non-GAAP measure) represents GAAP net sales growth excluding the impact of the change in foreign currency exchange rates. See reconciliation

on slide 67.

Long-Term Investment Case Remains Solid

• Investing behind leading brands to grow categories and share − 3%+ annual growth from innovation

− Advertising projected at about 10% of Sales in FY17

• Margin improvement opportunities continue to exist − Strong cost savings track record

− Driving SG&A to below 14% of sales

• Strong cash flow generation − Goal to generate Free Cash Flow of 10-12% of sales

− Recently announced +4% dividend increase

Cost Savings Continue to Deliver

0 bps

50 bps

100 bps

150 bps

200 bps

250 bps

FY13 FY14 FY15 FY16 FY17+

EBIT Margin Benefit from Cost Savings

+150bps

Annual

Goal

EBIT (a non-GAAP measure) represents earnings from continuing operations before income taxes (a GAAP measure), excluding interest income &

interest expense. EBIT margin is a measure of EBIT as a percentage of sales. See reconcilation on our website

(https://investors.thecloroxcompany.com/investors/financial-information/quarterly-results/default.aspx) and on slide 70 and 71.

Opportunities Exist Within SG&A

14.0%

5%

15%

25%

35%

45%

KHC CHD KMB GIS CLX PG K HSY RB-GB NWL COTY CL KO DPS PEP EL

% o

f S

ale

s

Goal: < 14% Sales

SG&A % of Sales as of Latest Fiscal Year End

CLX as of June 30th, 2016

Top-Tier ROIC

Peer Average: 15%

Return on invested capital (ROIC), a non-GAAP measure, is calculated as earnings from continuing operations before income taxes and interest expense,

computed on an after-tax basis as a percentage of average invested capital. Average invested capital represents a five quarter average of total assets less

non-interest bearing liabilities. ROIC is a measure of how effectively the company allocates capital. Information on the Peer ROIC is based on publicly

available Fiscal-end data (FactSet) as of 6/30/2016. See Slide 75 and 76 for reconciliation.

29%

0%

10%

20%

30%

CLX KMB CL HSY EL RB-GB DPS CHD CPB GIS PEP PG KO K COTY KHC NWL

$780 $786

$858

$768

$590 $649

$733

$596

FY13 FY14 FY15 FY16 Goal

$M

Operating Cash Flow Free Cash Flow

Strong Free Cash Flow

10% - 12%

of Sales

Free Cash Flow (a non-GAAP measure) represents Operating Cash Flow from Continuing Operations less Capital Expenditures. See reconcilation on our

website (https://investors.thecloroxcompany.com/investors/financial-information/quarterly-results/default.aspx) and on slide 73.

% of Sales

11% 12% 13% 10%

Use of Cash Priorities

Business Growth (includes targeted M&A)

Support Dividend

Share Repurchases Debt Leverage1

(Target: 2.0 – 2.5x)

Free

Cash

Flow

1. Debt Leverage = Gross Debt / EBITDA

M&A Focus

• Target areas with tailwinds in categories, countries, and channels Categories: Health & Wellness, Food Enhancers, and Natural Personal Care

Countries: US-Centric, with possible International expansion

Channels: Current retail and professional markets

• Strong fit with Clorox strategy and capabilities

• #1 (or strong #2) position in a defensible niche of a growing, sustainable category

• Accretive margin to the company average

• Balance Sheet Flexibility

Gross Debt/EBITA is 2.1x (low end of targeted range of 2.0x to 2.5x)

Please note that this slide refers to general goals for Clorox’s M&A focus – each element of focus may not be relevant or applicable to each M&A

potential transaction.

Nearly $2B Returned to Shareholders

in the Last 4 Years FY16

Dividend

Payout Ratio

= 61%

$590 $649

$733

$596

$330

$532 $568

$442

FY13 FY14 FY15 FY16

$ M

Free Cash Flow Cash Returned to Shareholders

Free Cash Flow (a non-GAAP measure) represents Operating Cash Flow from Continuing Operations less Capital Expenditures. See reconcilation on our

website (https://investors.thecloroxcompany.com/investors/financial-information/quarterly-results/default.aspx) and on slide 73.

Healthy Dividend Growth…

Dividends Have Increased Each Year Since 1977

0%

1%

2%

3%

4%

COTY KO KMB PG GIS K PEP KHC CLX CL HSY DPS CPB RB-GB NWL CHD EL

2.6% Peer Average: 2.5%

Dividend Yield as of Dec 31st, 2016

Long-Term Growth Algorithm Remains Unchanged


+2-4% annual growth

1.5 - 3.0 pts

company growth

U.S. Domestic


+5-7% annual growth

1.0 - 1.5 pts

company growth

International

Annual EBIT Margin Improvement: +25 to +50 bps

Annual Free Cash Flow: 10% to 12% of Sales

= +3 to +5pts company

growth

688 CLOROX

339 S&P 500

695 Peers

0

100

200

300

400

500

600

700

800

Dec96

Dec98

Dec00

Dec02

Dec04

Dec06

Dec08

Dec10

Dec12

Dec14

Dec16

CLX S&P 500 Peer Companies Average

TSR %

Strong Shareholder Return

Peer includes 13 companies: CPB, KMB, K, RB-GB, KO, GIS, NWL, EL, PEP, CHD, CL, PG and HSY

Total Shareholder Return

20 Year Ending 12/31/2016

Appendix

$ in B FY13 FY14 FY15 FY16

EBITDA $1.2 $1.1 $1.2 $1.2

Total Debt / EBITDA 2.1x 2.0x 1.8x 1.9x

EBITDA Interest Coverage 9.5x 11.3x 11.9x 14.0x

EBIT / Interest 8.0x 9.6x 10.2x 12.1x

Free Cash Flow / Debt 25% 28% 33% 26%

FCF after Dividends / Debt 10% 12% 16% 9%

FCF as % of sales 10% 12% 13% 10%

FCF after Dividends as % of Sales 4% 5% 6% 3%

Long Term Credit Ratings BBB+ /Baa1

BBB+/Baa1 BBB+/Baa1 A- / Baa1

CP Ratings A-2/P-2 A-2/P-2 A-2/P-2 A-2/P-2

Key Credit Metrics

Note: EBIT, EBITDA, FCF are Non-GAAP measures with reconciliations available on slides 70-74

Sales Growth Reconciliation

Second Quarter & FYTD Sales Growth Reconciliation

Q2 Fiscal 2017

Q2

Fiscal 2016

Q2 FYTD Fiscal 2017

Q2 FYTD Fiscal 2016

Total Net Sales Growth – GAAP 4.5% 0.0% 4.2% 1.4%

Less: Foreign exchange -1.9% -2.7% -1.9% -2.8%

Currency-Neutral Net Sales Growth – Non-GAAP(1)

6.4% 2.7% 6.1% 4.2%

Gross Margin Reconciliation

Reportable Segments (unaudited)

Dollars in Millions

(1) Percentages based on rounded numbers.

EBIT and EBITDA (unaudited)

Dollars in Millions

Footnotes on Slide 72


Dollars in Millions

Footnotes on Slide 72


Free Cash Flow (FCF) Reconciliation

Dollars in Millions

(1) In accordance with the SEC's Regulation G, this schedule provides the definition of certain non-GAAP measures and the reconciliation to the most

closely related GAAP measure. Management uses free cash flow and free cash flow as a percent of sales to help assess the cash generation ability of the

business and funds available for investing activities, such as acquisitions, investing in the business to drive growth, and financing activities, including debt

payments, dividend payments and share repurchases. Free cash flow does not represent cash available only for discretionary expenditures, since the

Company has mandatory debt service requirements and other contractual and non-discretionary expenditures. In addition, free cash flow may not be the same

as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded.

Free Cash Flow (FCF) Reconciliation

Dollars in Millions

(1) In accordance with the SEC's Regulation G, this schedule provides the definition of certain non-GAAP measures and the reconciliation to the most closely related GAAP measure.

Management uses free cash flow and free cash flow as a percent of sales to help assess the cash generation ability of the business and funds available for investing activities, such as

acquisitions, investing in the business to drive growth, and financing activities, including debt payments, dividend payments and share repurchases. Free cash flow does not represent

cash available only for discretionary expenditures, since the Company has mandatory debt service requirements and other contractual and non-discretionary expenditures. In addition, free

cash flow may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded.

Return on Invested Capital (ROIC) Reconciliation Dollars in millions and all calculations based on rounded numbers

FY16

$ 983

88

$ 1,071

$ (365)

$ 706

$ 2,457

29%Return on invested capital (1)

Earnings from continuing operations before income taxes


and interest expense

Average invested capital (3)

Income taxes on earnings from continuing operations before

income taxes and interest expense (2)

Interest expense

Adjusted after-tax profit

(1) In accordance with SEC's Regulation G, this schedule provides the definition of a non-GAAP measure and the reconciliation to the most closely related GAAP measure. Return on invested capital (ROIC), a non-GAAP measure, is calculated as earnings from continuing operations before income taxes and interest expense, computed on an after-tax basis as a percentage of average invested capital. Management believes ROIC provides additional information to investors about current trends in the business. ROIC is a measure of how effectively the company allocates capital.

(2) The tax rate applied is the effective tax rate on continuing operations, which was 34.1%.

(3) Average invested capital represents a five quarter average of total assets less non-interest bearing liabilities.

(Amounts shown below are five quarter averages) FY16

Total assets 4,247$

Less: non-interest bearing liabilities (1,790)

Average invested capital 2,457$

Return on Invested Capital (ROIC) Reconciliation

Dollars in millions and all calculations based on rounded numbers

FY16

$ 983

88

$ 1,071

$ (365)

$ 706

$ 2,457

29%Return on invested capital (1)



and interest expense

Average invested capital (3)

Income taxes on earnings from continuing operations before

income taxes and interest expense (2)

Interest expense

Adjusted after-tax profit

(1) In accordance with SEC's Regulation G, this schedule provides the definition of a non-GAAP measure and the reconciliation to the most closely related GAAP measure. Return on invested capital (ROIC), a non-GAAP measure, is calculated as earnings from continuing operations before income taxes and interest expense, computed on an after-tax basis as a percentage of average invested capital. Management believes ROIC provides additional information to investors about current trends in the business. ROIC is a measure of how effectively the company allocates capital.

(2) The tax rate applied is the effective tax rate on continuing operations, which was 34.1%.

(3) Average invested capital represents a five quarter average of total assets less non-interest bearing liabilities.

(Amounts shown below are five quarter averages) FY16

Total assets 4,247$

Less: non-interest bearing liabilities (1,790)

Average invested capital 2,457$

Dollars in millions and all calculations based on rounded numbers